Travere Therapeutics, Inc. TVTX Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Travere Therapeutics, Inc. (TVTX) reported operating lease right-of-use assets in other assets of $9.67M in Q1 2026.
- How has Travere Therapeutics, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Travere Therapeutics, Inc.'s operating lease right-of-use assets in other assets decreased by 26.7% year-over-year, from $13.2M to $9.67M.
- What is the long-term trend for Travere Therapeutics, Inc.'s operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s operating lease right-of-use assets in other assets has grown at a -16.3% compound annual growth rate (CAGR), from $25.68M to $10.58M.